Imdusiran (AB-729)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Imdusiran (AB-729), covering 2025-09-11 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B [Phase 2]